Seagen Inc.
Glycan-Interacting Compounds and Methods of Use

Last updated:

Abstract:

The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.

Status:
Application
Type:

Utility

Filling date:

26 May 2021

Issue date:

24 Feb 2022